Iwasaki Y, Porter K, Amend J, Marchioro T, Zuhlke V, Starzl T
Surg Gynecol Obstet. 1967; 124(1):1-24.
PMID: 6016025
PMC: 2682216.
Gray G, Mickelson M
Immunology. 1970; 19(3):417-28.
PMID: 5471827
PMC: 1455691.
JEEJEEBHOY H
J Exp Med. 1970; 132(5):963-75.
PMID: 5470511
PMC: 2138878.
DOI: 10.1084/jem.132.5.963.
Basten A, Beeson P
J Exp Med. 1970; 131(6):1288-305.
PMID: 5419272
PMC: 2138837.
DOI: 10.1084/jem.131.6.1288.
Levey R, Medawar P
Proc Natl Acad Sci U S A. 1966; 56(4):1130-7.
PMID: 5339289
PMC: 220018.
DOI: 10.1073/pnas.56.4.1130.
Symposium on immunosuppressive drugs. Attributes of clinically used immunosuppressive drugs: possible future uses of antilymphoid sera.
Starzl T, Marchioro T, Iwasaki Y
Fed Proc. 1967; 26(3):944-52.
PMID: 5337288
PMC: 3007094.
Use of anti-lymphocyte serum to prolong dog homograft survival.
HUNTLEY R, Taylor P, Iwasaki Y, Marchioro T, JEEJEEBHOY H, Porter K
Surg Forum. 1966; 17:230-3.
PMID: 5331810
PMC: 2991112.
Participation of three cell types in the anti-sheep red blood cell response in vitro. Separation of antigen-reactive cells from the precursors of antibody-forming cells.
Tan T, Gordon J
J Exp Med. 1971; 133(3):520-33.
PMID: 5165124
PMC: 2138949.
DOI: 10.1084/jem.133.3.520.
Metastatic spread of human tumour implanted into thymectomized, antithymocyte serum treated hamsters.
Cobb L
Br J Cancer. 1972; 26(3):183-9.
PMID: 5047142
PMC: 2008479.
DOI: 10.1038/bjc.1972.25.
Anti-lymphocytic antibody and autoimmune disease: a review.
DENMAN A
Clin Exp Immunol. 1969; 5(3):217-49.
PMID: 4980325
PMC: 1579119.
Anti-lymphocytic antibody--a review.
JAMES K
Clin Exp Immunol. 1967; 2(6):615-31.
PMID: 4966356
PMC: 1578801.
Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum.
Cinader B, JEEJEEBHOY H, Koh S, Rabbat A
J Exp Med. 1971; 133(1):81-99.
PMID: 4924199
PMC: 2138884.
DOI: 10.1084/jem.133.1.81.
Thymectomy and renal homotransplantation.
Starzl T, Porter K, Andres G, Groth C, Putnam C, Penn I
Clin Exp Immunol. 1970; 6(6):803-14.
PMID: 4920548
PMC: 1712811.
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains.
DENMAN A, Russell A, Denman E
Clin Exp Immunol. 1969; 5(6):567-95.
PMID: 4904067
PMC: 1579151.
Notes on the preparation and assay of anti-lymphocytic serum for use in mice.
Jooste S, Lance E, Levey R, Medawar P, Ruszkiewicz M, Sharman R
Immunology. 1968; 15(5):697-705.
PMID: 4880356
PMC: 1409531.
Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat.
JAMES K, ANDERSON N
Clin Exp Immunol. 1968; 3(3):227-31.
PMID: 4872719
PMC: 1578880.
Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.
JEEJEEBHOY H, Singla O
Immunology. 1972; 22(5):789-99.
PMID: 4553773
PMC: 1407848.
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.
Lance E
Clin Exp Immunol. 1970; 6(6):789-802.
PMID: 4394519
PMC: 1712818.
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody.
DENMAN A, Russell A, Denman E
Clin Exp Immunol. 1970; 6(3):325-35.
PMID: 4191824
PMC: 1712696.
Heterologous antilymphocyte globulin.
Starzl T
N Engl J Med. 1968; 279(13):700-3.
PMID: 4174895
PMC: 2757740.
DOI: 10.1056/NEJM196809262791309.
